Transcatheter Embolization and Occlusion Devices Market: By Product (Embolization particles, Embolization coils, Coiling Assist Devices, Accessories, Flow Diverter devices, Liquid Embolics), By Application (Oncology, Urology, Peripheral Vascular Disease, Neurology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

Transcatheter Embolization and Occlusion Devices Market size was estimated at USD x million in 2022 and is poised to grow at a CAGR of x% from 2023-2029. Transcatheter Embolization and Occlusion Devices Market Catheter embolization places medications or synthetic materials called embolic agents through a catheter into a blood vessel to block blood flow to an area of the body. It may be used to control or prevent abnormal bleeding, close off vessels supplying blood to a tumor, eliminate abnormal connections between arteries and veins, or treat aneurysms. Embolization is a highly effective way to control bleeding and is much less invasive than open surgery. In January 2018, Cerenovus has launched a next-generation embolic coil for the treatment of cerebral aneurysms and stroke. When compared to open invasive surgical procedures, transcatheter embolization is a less invasive and very effective technique to reduce bleeding. In the case of gastrointestinal bleeding, Transcatheter Embolization and Occlusion Devices Market are considered the first line of treatment. This procedure can be done on its own or in conjunction with other treatments including surgery or radiation. The procedure begins with the use of x-ray imaging to visualize the blood vessel, followed by the insertion of a catheter through the skin into the desired blood vessel and advancement to the treatment site by an interventional radiologist. This procedure, which interrupts the blood flow produced by uterine fibroid tumors, is a great alternative to hysterectomy in females for shrinking and controlling severe monthly bleeding.